Prokidney (PROK) Other Accumulated Expenses (2021 - 2026)
Prokidney (PROK) reported Other Accumulated Expenses of $1.4 million for Q1 2026, down 14.84% year-over-year from $1.6 million in Q1 2025, and up 106.45% quarter-over-quarter from $667000.0 in Q4 2025.
Prokidney (PROK) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Other Accumulated Expenses data on file, last reported at $1.4 million in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $1.4 million, down 14.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 14.84% YoY), and the FY2025 annual result was $667000.0, down 65.1% from the prior year.
- Other Accumulated Expenses rose to $1.4 million in Q1 2026 per PROK's latest filing, from $667000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $2.6 million in Q3 2024 and troughed at $21000.0 in Q4 2022.
- A 5-year average of $1.3 million and a median of $1.4 million in 2026 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses tumbled 85.91% in 2022, then surged 7214.29% in 2023.
- A 5-year view of Other Accumulated Expenses shows it stood at $21000.0 in 2022, then surged by 7214.29% to $1.5 million in 2023, then advanced by 24.41% to $1.9 million in 2024, then plunged by 65.1% to $667000.0 in 2025, then surged by 106.45% to $1.4 million in 2026.
- Business Quant data shows PROK's Other Accumulated Expenses at $1.4 million in Q1 2026, $667000.0 in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 667,000.00 |
| Sep 30, 2025 | 1.79 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 924,000.00 |
| Jun 30, 2023 | 542,000.00 |
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 537,000.00 |
| Dec 31, 2021 | 149,000.00 |